• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by Charles & Colvard Ltd

    9/30/25 5:20:02 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email
    NT 10-K 1 tm2527635d1_nt10k.htm NT 10-K

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549    

     

    FORM 12b-25

     

    SEC FILE NUMBER: 000-23329

    CUSIP NUMBER: 159765106

     

    NOTIFICATION OF LATE FILING

     

    (Check one):  

    x Form 10-K ¨  Form 20-F ¨  Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨  Form N-CEN

    ¨ Form N-CSR

         
        For Period Ended: June 30, 2025  
        ☐   Transition Report on Form 10-K
        ☐   Transition Report on Form 20-F
        ☐   Transition Report on Form 11-K
        ☐   Transition Report on Form 10-Q
         
        For the Transition Period Ended: _____________
     
    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I — REGISTRANT INFORMATION

     

    Charles & Colvard, Ltd.  
    Full Name of Registrant  
       
    N/A

    Former Name if Applicable

     

    170 Southport Drive
    Address of Principal Executive Office (Street and Number)
     
    Morrisville, NC 27560
    City, State and Zip Code

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

     (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    x  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN, or N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed date; and
       (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

     

     

     

    PART III — NARRATIVE

     

    State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

     

    Charles & Colvard, Ltd. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the “Form 10-K”). The Company was unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense because it requires additional time to complete procedures relating to its year-end financial statement and auditing processes. Ongoing litigation and shareholder activism requiring the Company to hold its annual meeting of shareholders prior to completion of the audit diverted valuable Company resources and management time, contributing to the delay. While the Company intends to file the Form 10-K as soon as practicable, the Company does not anticipate being able to file its Form 10-K within the fifteen-day grace period provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended.

     

    Based on the currently available information, and consistent with the Company’s disclosure in its Annual Report on Form 10-K for the fiscal year ended June 30, 2024, its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024, its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, and its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, the Company expects to disclose in its Form 10-K, that (1) certain material weaknesses exist in internal controls over financial reporting, and (2) certain factors raise substantial doubt about the Company’s ability to continue as a going concern. In response to this and the continued challenging economic environment, the Company continues to reduce spend across the board in order to stabilize and right-size its business as noted below in Part IV (3) with the decrease in total operating expense expected to be approximately 35% for fiscal year ended June 30, 2025 compared to the prior year. The Company has implemented a cost reduction strategy that includes a decrease in headcount and related payroll, executive salary reductions, reevaluation of its supplier base, and inventory repurposing – all through the fiscal year ended June 30, 2025, and in the quarter ended September 30, 2025. In addition, the Company, as part of its cash raising efforts, has liquidated certain of its inventory during the fiscal year ended June 30, 2025, particularly to pay off the Wolfspeed, Inc. settlement payment required in February 2025 totaling $2.3 million. The Company expects to report an approximately 37% decrease in its net loss for the fiscal year ended June 30, 2025 vs the prior year as noted below in Part IV (3).

     

    PART IV — OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

      Clint J. Pete   (919)   468-0399
      (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
     

    Yes   x No ¨

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
      Yes x    No¨

     

      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

     

     

    Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2025, the Company expects to report that total operating expense decreased by approximately 35% to approximately $12.8 million for the fiscal year ended June 30, 2025 compared to total operating expense of $19.8 million for the fiscal year ended June 30, 2024.

     

    Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2025, the Company expects to report net sales decreased by approximately 26% to approximately $16.3 million for the fiscal year ended June 30, 2025 compared to net sales of $22 million for the fiscal year ended June 30, 2024.

     

    Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2025, the Company expects to report that net loss decreased by approximately 37% to approximately $9.1 million for the fiscal year ended June 30, 2025 compared to net loss of $14.4 million reported for the year ended June 30, 2024. The foregoing figures are preliminary and unaudited and are prepared in accordance with U.S. generally accepted accounting principles. While the Company does not expect any significant changes to the estimates, such estimates remain subject to change pending the completion of the year-end financial statement review and audit.

     

    Forward-Looking Statements

     

    This filing contains a number of forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “plan,” “expect,” “will,” “working,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our beliefs and expectations relating to the filing of the Form 10-K and the estimated reporting of financial results. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond our control. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission. The Company disclaims and does not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation.

     

     

     

     

    Charles & Colvard, Ltd.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: September 30, 2025 By: /s/ Clint J. Pete
    Name: Clint J. Pete
    Title: Chief Financial Officer

     

     

     

    Get the next $CTHR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today. In June, Ethara Capital announced a Con

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

    RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

    4/22/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

    RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

    3/3/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    SEC Filings

    View All

    Charles & Colvard Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    10/16/25 4:30:36 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form NT 10-K filed by Charles & Colvard Ltd

    NT 10-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/30/25 5:20:02 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form D filed by Charles & Colvard Ltd

    D - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/12/25 4:40:28 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Ethara Capital Llc claimed ownership of 1,353,180 shares (SEC Form 3)

    3 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    10/9/25 3:30:05 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Charles & Colvard with a new price target

    Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

    9/3/21 8:46:46 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 9:15:15 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/26/24 7:00:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

    SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/14/24 9:00:30 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    11/20/23 4:15:12 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    View All

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

    5/2/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

    4/23/24 4:08:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

    2/13/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

    ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

    11/14/24 4:00:00 PM ET
    $CTHR
    $MLSS
    Consumer Specialties
    Consumer Discretionary
    Industrial Specialties
    Health Care

    Charles & Colvard Joins Russell Microcap® Index

    RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

    6/28/21 9:16:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary